Abbott’s Phase III Fenofibrate Works With Statins
This article was originally published in The Pink Sheet Daily
Executive Summary
The “how” of lipid-lowering could prove key, analyst tells “The Pink Sheet” DAILY.
You may also be interested in...
TriLipix Approval Strengthens Abbott’s Cholesterol Franchise
FDA approval of Abbott's next-generation fenofibrate TriLipix (fenofibric acid) reinforces the drug maker's position in the lucrative but maturing cholesterol market
TriLipix Approval Strengthens Abbott’s Cholesterol Franchise
FDA approval of Abbott's next-generation fenofibrate TriLipix (fenofibric acid) reinforces the drug maker's position in the lucrative but maturing cholesterol market
Analysts Bullish On Crestor After Strong JUPITER Data
JPMorgan raises global sales estimate but cautions that AstraZeneca has under-invested in the statin.